Type of MS: SPMS
Treatment mode of action: To improve immune function
Number of Subjects: 1700
Medication: SAR442168 (Inhibiting B-cell receptor signaling by blocking BTK disease activity)
Location: Washington
Institutions: Inland Northwest Research
610 S Sherman St. Suite 208
Spokane, WA 99202
Contact Information
Deann Dickinson, ext. 704
509-960-2818
ddickinson@inwresearch.com